Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 2015 item(s)
JERUSALEM, March 10, 2021 /PRNewswire-AsiaNet/ -- Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The...
AMERSHAM, United Kingdom, March 9, 2021 /PRNewswire-AsiaNet/ -- - A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and governm...
SYDNEY, March 8, 2021 /PRNewswire-AsiaNet/ -- Leading patient outcomes journal Patient Preference and Adherence [ https://doi.org/10.2147/PPA.S293941 ] has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular de...
NYON, Switzerland, March 4, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR(TM), its ...
MUMBAI, India, 02 March 2021 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087); (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Foo...
MUMBAI, India, March. 2, 2021/PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf')is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines ...
PLYMOUTH MEETING, Pa., March 2, 2021 /PRNewswire-AsiaNet/ -- -- Trial achieved primary and secondary efficacy endpoints among all evaluable subjects in the Phase 3 multi-center, randomized, double-blind, placebo-controlled trial -- VGX-3100 is the first DNA medicine to achieve efficacy endpoints in a Pha...
MIAMI, March 1, 2021 /PRNewswire-AsiaNet/ -- Lennar Corporation (NYSE: LEN and LEN.B), the nation's leading homebuilder, today announced that it has been named #1 Most Admired Homebuilder on FORTUNE Magazine's 2021 List of World's Most Admired Companies ( https://c212.net/c/link/?t=0&l=en&o=...
SINGAPORE, March 1, 2021 /PRNewswire-AsiaNet/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announces the successful sale of its portfolio company Cambridge Medical and Rehabilitation Center ("CMRC") to UAE-based publicly traded ...
LAUSANNE, Switzerland and SEONGNAM-SI GYEONGGI-DO, South Korea, Feb. 26, 2021 /PRNewswire/ - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncolo...

Previous Page Page 7 of 202 Next Page ...  2  3  4  5  6  7  8  9  10  11  ... Go to page Go